Showing results (301-310 of 1,028) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|March 14, 2022
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trialHarm A W M Tiddens, Yuxin Chen, Eleni-Rosalina Andrinopoulou, et al.The Lancet. Respiratory Medicine|April 1, 2022
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challengesDavid J Birnkrant, Luca Bello, Russell J Butterfield, et al.The Lancet. Respiratory Medicine|September 19, 2018
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trialKlaus F Rabe, Henrik Watz, Simonetta Baraldo, et al.The Lancet. Respiratory Medicine|September 19, 2018
Long-term developmental effects of withholding parenteral nutrition for 1 week in the paediatric intensive care unit: a 2-year follow-up of the PEPaNIC international, randomised, controlled trialSören Verstraete, Sascha C Verbruggen, José A Hordijk, et al.The Lancet. Respiratory Medicine|September 6, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studiesPierre-Régis Burgel, Jennifer Da Silva, Emmanuelle Girodon, et al.The Lancet. Respiratory Medicine|May 20, 2017
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised studyJohn H Beigel, Pablo Tebas, Marie-Carmelle Elie-Turenne, et al.The Lancet. Respiratory Medicine|May 21, 2017
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trialDaniel F McAuley, Lj Mark Cross, Umar Hamid, et al.The Lancet. Respiratory Medicine|June 19, 2017
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort studyJohn G Laffey, Fabiana Madotto, Giacomo Bellani, et al.The Lancet. Respiratory Medicine|April 10, 2018
Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studiesDanielle C M Belgrave, Raquel Granell, Steve W Turner, et al.The Lancet. Respiratory Medicine|July 1, 2017
Novel translational approaches to the search for precision therapies for acute respiratory distress syndromeNuala J Meyer, Carolyn S CalfeePageof 103